2006Journal of Bengbu Medical CollegeRequires access

The pharmacokinetics and relative bioavailability of levofloxacin hydrochloride capsule in healthy volunteers

Zhiwen Jiang

Open publisher page 1 citations

Abstract

Objective:To investigate the pharmacokinetics and bioequivalence of levofloxacin hydrochloric capsule.Methods:Twenty healthy subjects took oral levofloxacin hydrochloric capsule in the case.The high performance liquid chromatography(HPLC) method was established to determine blood serum concentration and the bioequivalence of the two formulations were evaluated by the analysis of variance and the two one-sided t-test with DAS1.0.Results: The pharmacokinetic parameters of the testee and references were as follows:t_ 1/2 (5.24±1.58) h and(5.50±2.05) h,C_ max (2.75±0.61) mg/L and(2.55±0.61) mg/L;T_ max (0.99±0.56) h and (1.05 ±0.54) h,AUC_ 0-24 (21.53±3.36) mg·L -1 ·h -1 and(20.61±3.67) mg·L -1 ·h -1 ,AUC_ 0-∞ (23.87±3.92) mg·L -1 ·h -1 and(23.05±4.45) mg·L -1 ·h -1 ,respectively.Relative bioavailability was(108.82±30.75)%.Conclusions:The two preparations are of bioequivalence.

About this research paper

What this paper is about

Objective:To investigate the pharmacokinetics and bioequivalence of levofloxacin hydrochloric capsule.Methods:Twenty healthy subjects took oral levofloxacin hydrochloric capsule in the case.The high performance liquid chromatography(HPLC) method was established to determine blood serum concentration and the bioequivalence of the two formulations were evaluated by the analysis of variance and the two one-sided t-test with DAS1.0.Results: The pharmacokinetic parameters of the testee and references were as follows:t_ 1/2 (5.24±1.58) h and(5.50±2.05) h,C_ max (2.75±0.61) mg/L and(2.55±0.61) mg/L;T_ max (0.99±0.56) h and (1.05 ±0.54) h,AUC_ 0-24 (21.53±3.36) mg·L -1 ·h -1 and(20.61±3.67) mg·L -1 ·h -1 ,AUC_ 0-∞ (23.87±3.92) mg·L -1 ·h -1 and(23.05±4.45) mg·L -1 ·h -1 ,respectively.Relative bioavailability was(108.82±30.75)%.Conclusions:The two preparations are of bioequivalence.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the pharmacokinetics and bioequivalence of levofloxacin hydrochloric capsule.Methods:Twenty healthy subjects took oral levofloxacin hydrochloric capsule in the case.The high performance liquid chromatography(HPLC) method was established to determine blood serum concentration and the bioequivalence of the two formulations were evaluated by the analysis of variance and the two one-sided t-test with DAS1.0.Results: The pharmacokinetic parameters of the testee and references were as follows:t_ 1/2 (5.24±1.58) h and(5.50±2.05) h,C_ max (2.75±0.61) mg/L and(2.55±0.61) mg/L;T_ max (0.99±0.56) h and (1.05 ±0.54) h,AUC_ 0-24 (21.53±3.36) mg·L -1 ·h -1 and(20.61±3.67) mg·L -1 ·h -1 ,AUC_ 0-∞ (23.87±3.92) mg·L -1 ·h -1 and(23.05±4.45) mg·L -1 ·h -1 ,respectively.Relative bioavailability was(108.82±30.75)%.Conclusions:The two preparations are of bioequivalence.

Key concepts: Bioequivalence, Pharmacokinetics, Bioavailability, Medicine, Levofloxacin, Capsule, High-performance liquid chromatography, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
The pharmacokinetics and relative bioavailability of levofloxacin hydrochloride capsule in healthy volunteers — Research Paper | ScholarLens